Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability
Top Cited Papers
- 1 June 2002
- Vol. 109 (6) , 707-718
- https://doi.org/10.1016/s0092-8674(02)00762-6
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Dominant role of the niche in melanocyte stem-cell fate determinationNature, 2002
- Microphthalmia transcription factorCancer, 2001
- Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi MiceMolecular Cell, 2001
- The Gene Encoding the T-box Factor Tbx2 Is a Target for the Microphthalmia-associated Transcription Factor in MelanocytesJournal of Biological Chemistry, 2000
- Regulation of Microphthalmia-Associated Transcription Factor MITF Protein Levels by Association with the Ubiquitin-Conjugating Enzyme hUBC9Experimental Cell Research, 2000
- Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertilityNature Genetics, 2000
- Bcl-2 family proteinsOncogene, 1998
- Expression monitoring by hybridization to high-density oligonucleotide arraysNature Biotechnology, 1996
- Bcl-2 expression in malignant melanoma and its prognostic significanceEuropean Journal of Surgical Oncology, 1996
- Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.The Journal of Experimental Medicine, 1996